Carillon Tower Advisers, an investment management company, released its first-quarter 2026 investor letter for the “Carillon Eagle Small Cap Growth Fund”. A copy of the letter can be downloaded here. Small-cap stocks delivered mixed results in the quarter as the market favored value stocks over growth. The Russell 2000 Growth Index fell 2.82% in the quarter, while the Russell 2000® Value Index increased 4.96%. The first quarter saw equity market volatility due to Iran strikes, boosting energy prices. The firm is optimistic that the turbulence in the market will be short-lived, with improved valuations and potential positive developments from de-escalation in the Middle East. In addition, please check the Fund’s top five holdings to know its best picks in 2026.
In its first-quarter 2026 investor letter, Carillon Eagle Small Cap Growth Fund highlighted IRhythm Holdings, Inc. (NASDAQ:IRTC). IRhythm Holdings, Inc. (NASDAQ:IRTC) is a digital healthcare company that provides Zio ambulatory cardiac monitoring services. The company, previously known as iRhythm Technologies, Inc., changed its name to iRhythm Holdings, Inc. in January 2026. On June 24, 2026, IRhythm Holdings, Inc. (NASDAQ:IRTC) closed at $112.47 per share. One-month return of IRhythm Holdings, Inc. (NASDAQ:IRTC) was -2.72%, and its shares lost 26.34% over the past 52 weeks. IRhythm Holdings, Inc. (NASDAQ:IRTC) has a market capitalization of $3.7 billion.
Carillon Eagle Small Cap Growth Fund stated the following regarding IRhythm Holdings, Inc. (NASDAQ:IRTC) in its Q1 2026 investor letter:
“IRhythm Holdings, Inc. (NASDAQ:IRTC) is a digital healthcare company that develops wearable, AI-driven cardiac monitoring devices. The stock struggled despite delivering beat-and-raise results. Broader weakness in the healthcare equipment and supplies industry, as investors rotated into cyclical and technology stocks, weighed on performance. Additional pressure came from a US Department of Justice Civil Investigative Demand (DOJ CID) received in December related to mobile cardiac telemetry services rendered in 2023 via iRhythm’s Zio AT recording device. This inquiry is limited in scope as it only accounts for a small portion of total sales and the risk has already been priced in. We don’t read too much into the com pany’s recent change of auditors.”
IRhythm Holdings, Inc. (NASDAQ:IRTC) is not on our list of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. According to our database, 37 hedge fund portfolios held IRhythm Holdings, Inc. (NASDAQ:IRTC) at the end of the first quarter, compared to 44 in the previous quarter. While we acknowledge the risk and potential of IRhythm Holdings, Inc. (NASDAQ:IRTC) as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than IRhythm Holdings, Inc. (NASDAQ:IRTC) and that has 10,000% upside potential, check out our report about this cheapest AI stock.
In another article, we covered IRhythm Holdings, Inc. (NASDAQ:IRTC) and shared Artisan Small Cap Fund’s views on the company. In addition, please check out our hedge fund investor letters Q1 2026 page for more investor letters from hedge funds and other leading investors.
READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years.
Disclosure: None. This article is originally published at Insider Monkey.
